217 related articles for article (PubMed ID: 17343556)
1. Age onset subtypes of obsessive compulsive disorder: differences in clinical response to treatment with clomipramine.
Ulloa RE; Nicolini H; Avila M; Fernández-Guasti A
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):85-96. PubMed ID: 17343556
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
Zohar J; Judge R
Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
Varigonda AL; Jakubovski E; Bloch MH
J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
[TBL] [Abstract][Full Text] [Related]
4. Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
Albert U; Aguglia E; Maina G; Bogetto F
J Clin Psychiatry; 2002 Nov; 63(11):1004-9. PubMed ID: 12444814
[TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.
Koran LM; McElroy SL; Davidson JR; Rasmussen SA; Hollander E; Jenike MA
J Clin Psychopharmacol; 1996 Apr; 16(2):121-9. PubMed ID: 8690827
[TBL] [Abstract][Full Text] [Related]
6. Citalopram for treatment-resistant obsessive-compulsive disorder.
Pallanti S; Quercioli L; Paiva RS; Koran LM
Eur Psychiatry; 1999 Apr; 14(2):101-6. PubMed ID: 10572334
[TBL] [Abstract][Full Text] [Related]
7. Adults with early-onset obsessive-compulsive disorder.
Rosario-Campos MC; Leckman JF; Mercadante MT; Shavitt RG; Prado HS; Sada P; Zamignani D; Miguel EC
Am J Psychiatry; 2001 Nov; 158(11):1899-903. PubMed ID: 11691698
[TBL] [Abstract][Full Text] [Related]
8. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.
Figueroa Y; Rosenberg DR; Birmaher B; Keshavan MS
J Child Adolesc Psychopharmacol; 1998; 8(1):61-7. PubMed ID: 9639080
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients.
Marazziti D; Golia F; Consoli G; Presta S; Pfanner C; Carlini M; Mungai F; Catena Dell'osso M
CNS Spectr; 2008 Nov; 13(11):971-6. PubMed ID: 19037176
[TBL] [Abstract][Full Text] [Related]
10. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
11. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
12. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents.
de Haan E; Hoogduin KA; Buitelaar JK; Keijsers GP
J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1022-9. PubMed ID: 9785713
[TBL] [Abstract][Full Text] [Related]
13. Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder.
Koran LM; Aboujaoude E; Ward H; Shapira NA; Sallee FR; Gamel N; Elliott M
J Clin Psychopharmacol; 2006 Feb; 26(1):79-83. PubMed ID: 16415712
[TBL] [Abstract][Full Text] [Related]
14. Side effects as predictors of drug response in obsessive-compulsive disorder.
Ackerman DL; Greenland S; Bystritsky A
J Clin Psychopharmacol; 1999 Oct; 19(5):459-65. PubMed ID: 10505588
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC
Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
[TBL] [Abstract][Full Text] [Related]
16. Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs).
Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G
Psychopharmacol Bull; 1996; 32(1):167-73. PubMed ID: 8927668
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
[TBL] [Abstract][Full Text] [Related]
18. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
Landeros-Weisenberger A; Bloch MH; Kelmendi B; Wegner R; Nudel J; Dombrowski P; Pittenger C; Krystal JH; Goodman WK; Leckman JF; Coric V
J Affect Disord; 2010 Feb; 121(1-2):175-9. PubMed ID: 19577308
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacologic treatment of obsessive compulsive disorder in the child and adolescent].
Flament MF
Encephale; 1993; 19(2):75-81. PubMed ID: 8275900
[TBL] [Abstract][Full Text] [Related]
20. Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder.
Karameh WK; Khani M
Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26221004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
